MHB036C

· Minghui Pharmaceutical (Hangzhou) Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MHB036C, covering 2025-11-17 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MHB036C for Advanced Solid Tumor [Phase 1, Phase 2]